Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9336419 | Brachytherapy | 2005 | 5 Pages |
Abstract
Sixteen patients considered to receive relatively high chest wall doses had less than one-third of their primary rib volume being exposed to the estimated TD 5/5 and TD 50/5 doses. Therefore, we estimate the risk of late effects in women treated with MBT, the balloon catheters of which placed near the ribs were negligible, and believe that MBT remains a safe and effective treatment for selected patients with early stage breast cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Anthony E. Dragun, Eric G. Aguero, Joseph F. Harmon, Jennifer L. Harper, Joseph M. Jenrette,